769 million. That’s how many lives our products touched in 2020.
The Medical Area Head, Cell and Gene Therapy (CAR-T) will lead a Medical Affairs team, with strategic partnership into medical brand teams as well as other brand related functions throughout the compound’s life cycle.
Your responsibilities:
Your responsibilities include, but are not limited to:
• Team leadership of the Medical Cell & Gene (CAR-T) team, with specialist Cell Therapy Medical Managers focusing on strategic delivery of the Novartis CAR-T Cell & Gene medical strategy and tactics to generate innovative value to customers and patients
• Provide medical input on the evidence gap analysis and competitors’ landscape in conjunction with other functions (e.g. RWE, Drug Development) to support evidence generation decision making, as well as to drive activity planning, execution and reporting (interventional and/or non-interventional studies).
• Perform key activities related to planning, execution and reporting of Medical Affairs studies and ensure timely and on budget delivery.
• Develop, contribute and review presentation materials for study/program-related advisory boards, investigator meetings, protocol training meetings, etc.
• Serve as disease area medical expert for internal partners from different line functions as well as external customers, including health care professionals, and patient advocacy groups.
• Alongside the Cell Therapy Medical Managers, build the Medical Affairs strategy and plans, publications, internal and external educational activities as well as other communication activities involving Medical Experts.
• Provide capability building plan for field medical associates, including disease area and product specific content to train region or country medical associates.
• Provide medical scientific input for brand/program documents, including integrated disease area plans, Medical Information documents, Drug Safety reporting documents, etc.
• Review and approve promotional and non-promotional materials to ensure accuracy and appropriate compliance, according to Ethics and Compliance Professional Practices Policy (P3).
